Chronic myelogenous leukemia: The news you have and haven't heard

Article Type
Changed
Fri, 02/01/2019 - 08:18
Display Headline
Chronic myelogenous leukemia: The news you have and haven't heard
Article PDF
Author and Disclosure Information

Matt E. Kalaycio, MD
Director, Leukemia Program, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Matt E. Kalaycio, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kalaycm@ccf.org

Dr. Kalaycio has indicated that he has received grant research support from Sangstat, Novartis, Genta, and Protein Design Labs, and that he is on the speakers bureau of Cell Therapeutics.

This article disscusses therapies that are not yet FDA-approved for the use under discussion and are investigational.

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Topics
Page Number
913, 917, 920-921, 925-926
Sections
Author and Disclosure Information

Matt E. Kalaycio, MD
Director, Leukemia Program, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Matt E. Kalaycio, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kalaycm@ccf.org

Dr. Kalaycio has indicated that he has received grant research support from Sangstat, Novartis, Genta, and Protein Design Labs, and that he is on the speakers bureau of Cell Therapeutics.

This article disscusses therapies that are not yet FDA-approved for the use under discussion and are investigational.

Author and Disclosure Information

Matt E. Kalaycio, MD
Director, Leukemia Program, Department of Hematology and Medical Oncology, The Cleveland Clinic

Address: Matt E. Kalaycio, MD, Department of Hematology and Medical Oncology, R35,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; kalaycm@ccf.org

Dr. Kalaycio has indicated that he has received grant research support from Sangstat, Novartis, Genta, and Protein Design Labs, and that he is on the speakers bureau of Cell Therapeutics.

This article disscusses therapies that are not yet FDA-approved for the use under discussion and are investigational.

Article PDF
Article PDF
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
913, 917, 920-921, 925-926
Page Number
913, 917, 920-921, 925-926
Publications
Publications
Topics
Article Type
Display Headline
Chronic myelogenous leukemia: The news you have and haven't heard
Display Headline
Chronic myelogenous leukemia: The news you have and haven't heard
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media